文献速递心脏核医学

核心脏病学的面貌变迁:引导心血管诊疗走向分子医学

The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine.
PubMed 文献 · J Nucl Med · 2020-04-17

放射性核素心肌灌注、功能与存活心肌显像已确立数十年,仍是缺血性心脏病临床评估与治疗指导的可靠循证手段。但替代模态的竞争日益加剧,而示踪剂原理可超越生理与功能评估、 interrogate 生物学与分子通路,成为核素显像的独特卖点。检测心肌浸润、器械感染与心血管炎症的分子影像方法正成功获得临床认可,分子靶向诊疗的共生需求进一步强化这一趋势。

要点

  • 放射性核素心肌灌注、功能与存活心肌显像仍是缺血性心脏病临床评估与治疗指导的可靠循证手段。
  • 示踪剂原理可超越生理与功能评估,实现对生物学与分子通路的探查,是核素显像的独特卖点。
  • 检测心肌浸润、器械感染与心血管炎症的分子影像方法正成功获得临床认可。

核心结论

  • 心血管分子影像的临床应用正在兴起,对心血管治疗从机械干预与广泛重磅药物治疗向新型个体化分子靶向及分子影像引导治疗的演变具有变革性贡献。

研究设计与样本

  • 综述,总结当前临床心血管分子影像的出现及其对心血管治疗演变的变革性贡献。

主要发现

  • 检测心肌浸润、器械感染与心血管炎症的分子影像方法正成功获得临床认可。
  • 心脏影像与治疗的共生需求推动分子靶向操作日益实施,特定治疗干预需要特定诊断指导以筛选最合适候选者。
  • 强有力的替代模态已出现并导致竞争日益加剧。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Radionuclide imaging of myocardial perfusion, function, and viability has been established for decades and remains a robust, evidence-based and broadly available means for clinical workup and therapeutic guidance in ischemic heart disease. Yet, powerful alternative modalities have emerged for this purpose, and their growth has resulted in increasing competition. But the potential of the tracer principle goes beyond the assessment of physiology and function, toward the interrogation of biology and molecular pathways. This is a unique selling point of radionuclide imaging, which has been underrecognized in cardiovascular medicine until recently. Now, molecular imaging methods for the detection of myocardial infiltration, device infection, and cardiovascular inflammation are successfully gaining clinical acceptance. This is further strengthened by the symbiotic quest of cardiac imaging and therapy for an increasing implementation of molecule-targeted procedures, in which specific therapeutic interventions require specific diagnostic guidance toward the most suitable candidates. This review will summarize the current advent of clinical cardiovascular molecular imaging and highlight its transformative contribution to the evolution of cardiovascular therapy beyond mechanical interventions and broad blockbuster medication, toward a future of novel, individualized molecule-targeted and molecular imaging-guided therapies.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Werner RA, Thackeray JT, Diekmann J, et al. The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine. J Nucl Med. 2020. PMID: 32303601. doi:10.2967/jnumed.119.240440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。